Last updated: February 21, 2024
Sponsor: Foundation for Angelman Syndrome Therapeutics, Australia
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Observational study only
Clinical Study ID
NCT05293184
RG-16-078-AM01
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of Angelman Syndrome
Exclusion
Exclusion Criteria:
Study Design
Total Participants: 5000
Treatment Group(s): 1
Primary Treatment: Observational study only
Phase:
Study Start date:
September 28, 2016
Estimated Completion Date:
December 31, 2099
Connect with a study center
Queensland University of Technology
Brisbane, Queensland 4000
AustraliaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.